RxDoctor Payments Data

Melanie Rose, MD

Vascular Surgery · Mobile, ALNPI 1134386964

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,665 of the $2,765 with a category attached, or 60.2%. It is spread thinly across 23 manufacturers, the largest accounting for just 22.4%. Reporting peaked in 2023 at $955 and has fallen 63.6% since, to $348 in 2025. That places this record below the midpoint for vascular surgery clinicians in AL, where the typical reported total is $5,256.

$2,765in general payments, 2019–2025

Across 62 payments — averaging $44.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Silk Road Medical, Inc.$620
  • Inari Medical, Inc.$518
  • Endologix LLC$343
  • Cook Medical LLC$192
  • Lemaitre Vascular, Inc.$148
  • Boston Scientific$131
  • plus $812 from 17 others

What the payments were for

  • Consulting fees$1,10040%
  • Food & beverage$1,66560%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,765 in reported general payments places this provider in the 30th percentile of 61 vascular surgery providers in Alabama.

See all vascular surgery providers in Alabama

Medicare billing

Part B allowed, 2024
$185,844
Medicare patients
287
Services billed
849

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban51$46,356
Midodrine Hcl25$1,501
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen191$1,076
ClopidogrelClopidogrel Bisulfate96$953
Lidocaine-PrilocaineLidocaine/Prilocaine25$336
Atorvastatin Calcium38$301
Cephalexin47$271
Methylprednisolone14$124
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim20$82

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Mobile

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →